Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
about
Concomitant pathologies among a spectrum of parkinsonian disordersMultiprotein deposits in neurodegenerative disorders: our experience in the tissue brain bank of Navarra.Comparing Cerebral White Matter Lesion Burdens between Parkinson's Disease with and without Dementia.Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlatesPrevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body DisordersPhosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsyPlaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinationsPathological alpha-synuclein propagates through neural networksCerebrospinal fluid biomarkers for dementia with lewy bodies.Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.Parkinson's disease, cortical dysfunction, and alpha-synuclein.Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative DiseasesPhosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologies.Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's diseaseAbsence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy.Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human α-synuclein: feasibility study.Basic mechanisms of neurodegeneration: a critical update.Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.Interaction between pathogenic proteins in neurodegenerative disorders.Clinicopathological correlates of lewy body disease: fundamental issues.Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.Multicenter Assessment of Immunohistochemical Methods for Pathological Alpha-Synuclein in Sigmoid Colon of Autopsied Parkinson's Disease and Control Subjects.Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease.MultiTEP platform-based DNA vaccines for alpha-synucleinopathies: preclinical evaluation of immunogenicity and therapeutic potency.Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition.A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Interaction between α-synuclein and other proteins in neurodegenerative disorders.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome.Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyImpaired hepatic amyloid-beta degradation in Alzheimer's disease
P2860
Q28236077-29DF286C-A3BE-4F92-BBA9-DCC0703FD8ACQ33453702-2D79B1CF-2A8A-4494-8C8D-E0792691EA32Q33636257-27CC9293-C0F6-41A3-8F31-47A12A6D3C85Q33683377-BAEA147C-0A88-4F1F-9503-896BE406FC52Q33874572-97AB81F6-E033-46AD-B7EA-853ACE4F7013Q33984304-DFCB9FBB-B20A-49E1-820C-3A2E7CBD3CA5Q34084369-39212BD2-F78E-4084-AF73-24C076903407Q34100338-DB260F2F-1A54-47E4-8D70-43D15E26E878Q34248241-3239D8DF-60ED-45F2-8399-92F1CC00D1E7Q34591096-AE784CB5-EACD-4980-A397-8D7CA44B2F44Q35161124-95D816E7-9564-4EED-970C-CDD8F25A3E2FQ35977445-F4BA964C-F0F7-47EF-BE53-1FFC747AF458Q36115621-7759FDAE-B13B-4F48-B4F9-D3659B803F50Q36852905-46264E22-15B8-4FB8-8E61-43CBF4E8FF9CQ36951533-B4A320D8-8063-4C1B-AD9F-44EE0801D71BQ37038032-BD0DB076-90E4-42BB-B606-36E34C73FCAAQ37062735-06F97EAA-CF51-4C84-B30B-660E57377BE3Q37315558-3CF22B83-739B-45F4-9494-13C55AABD3A2Q37376010-2B6E3676-7B7F-4B51-81B3-05B37AC55C2FQ37592238-C6316C8F-F6E4-4BF8-93A5-6FD51AB7891CQ37673274-E0C6238F-32ED-4A00-891D-3B8550D0ABB5Q37955871-A8ACFA3F-4C5E-48AE-B91A-76AE191BD9C6Q37969262-D9B993AD-AB42-43BD-B25A-08FB7253BBFEQ38215509-FB3E1EB7-1780-4656-81A6-C74D7679F6C2Q38311234-299D1038-D5FC-49A8-82AB-4E9BCD273DE6Q38377819-A8B7436F-CBE6-41B7-A64E-3B6EC909748AQ38669105-235A6E54-2F78-4DD2-A633-6A0B273A0E4AQ38942580-6C0DCEAA-F94F-4931-BDC3-E62910807D8EQ40108542-40CF6A98-FC9E-4F40-8764-78F46C3F5C21Q41589030-D90A1CB4-44C5-445A-B099-9F4F3E9E804AQ45291590-4E816124-34D9-44D2-9EEE-6AF1C2B76DB0Q45304017-47AFA807-AF74-4C44-8B4B-47982B1C7F48Q48002156-B670D7C3-3E7C-4C01-B1DE-680960E352F1Q49613405-A31DA91E-BFA7-4D64-A411-7ADA7ADD5D05Q49987358-2F4316D5-04C7-4BB3-8D61-688F6E5EBE10Q53324250-26C0824A-97D0-4BC9-BAE5-AC9BC27A73EDQ54982491-2B69F5CB-2D4A-4434-9A1F-09AA80F07941Q55455361-97FCF347-9019-4216-900D-C29220A2ECA4Q56504087-9F01991E-4CE4-46AF-BE85-C461FEFC5C68Q58759988-3E4DF132-B922-4F83-8CAE-E98F1F7A2C39
P2860
Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Relationship of phosphorylated ...... of dementia with Lewy bodies.
@en
Relationship of phosphorylated ...... of dementia with Lewy bodies.
@nl
type
label
Relationship of phosphorylated ...... of dementia with Lewy bodies.
@en
Relationship of phosphorylated ...... of dementia with Lewy bodies.
@nl
prefLabel
Relationship of phosphorylated ...... of dementia with Lewy bodies.
@en
Relationship of phosphorylated ...... of dementia with Lewy bodies.
@nl
P2093
P1476
Relationship of phosphorylated ...... of dementia with Lewy bodies.
@en
P2093
Haruhiko Akiyama
Hideki Mochizuki
Hiromi Kondo
Kimiko Obi
Masato Hasegawa
Takeshi Iwatsubo
Yoko Shimomura
P304
P356
10.1016/J.EXPNEUROL.2007.11.019
P407
P577
2007-12-03T00:00:00Z